Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Geniom Technology Applied to Targeted Next-Generation Sequencing

Published: Tuesday, July 24, 2007
Last Updated: Wednesday, July 25, 2007
Bookmark and Share
By enabling selective targeting, the Geniom® Biochip will allow researchers to sequence individual and well defined parts of genomes

febit biotech gmbh has achieved a first milestone in a product development project whose outcome should remove one of the major bottlenecks of next-generation sequencing platforms.

By enabling selective targeting, the Geniom® Biochip will allow researchers to sequence individual and well defined parts of genomes. Many scientists believe that such targeted sequencing – especially in the medical and diagnostic context - will be a significant application in genomics.

The project is carried out in conjunction with the Illumina/Solexa platform as representative of Next-Generation DNA sequencing instruments. The application might as well serve users of other systems such as the 454 sequencer instrument and the ABI/Agencourt system. febit’s work is a continuation of earlier research addressing uses of its Geniom microfluidic microarray technology.

febit CSO Peer Stahler: “We strongly believe that the products and services resulting from this project will open important and innovative analytical windows on the Genome. The resulting applications could change the way DNA sequence information is used in research and medical diagnostics. We are working with several partners in this field and expect first products to be available in 2008.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Febit Establishes US Company
Febit launches the GENIOM biochip system in the US.
Tuesday, August 15, 2006
Febit Achieves Sales Goals
Febit successfully markets the GENIOM bioanalysis device.
Thursday, March 16, 2006
Scientific News
World’s Largest Coral Gene Database
‘Genetic toolkit’ will help shed light on which species survive climate change.
Early Genetic Changes in Premalignant Colorectal Tissue Identified
Findings point to drivers of early cancer development, targets for cancer prevention therapies.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Modified Microalgae Converts Sunlight into Valuable Medicine
A special type of microalgae can soon produce valuable chemicals such as cancer treatment drugs and much more just by harnessing energy from the sun.
Breakthrough Approach to Breast Cancer Treatment
Scripps scientists have designed a drug candidate that decreases growth of breast cancer cells.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
A Guide to CRISPR Gene Activation
A comparison of synthetic gene-activating Cas9 proteins can help guide research and development of therapeutic approaches.
Gene That Lowers Heart Attack Risk Identified
Individuals with a rare twelve-letter deletion from a gene on chromosome 17 have significantly reduced non-HDL cholesterol levels and a 35% lower than average risk of heart disease.
Testing Non-Breast/Ovarian Cancer Genes
Researchers have found that expanding gene panel beyond breast/ovarian cancer genes in these patients does not add any clinical benefit. Instead, testing has produced more questions than answers.
Myeloid-Derived Suppressor Cells Play Role in Tumor Growth
Researchers at Baylor College of Medicine have reported a new mechanism that helps cancer cells engage myeloid-derived suppressor cells.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!